SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001628280-22-018405
Filing Date
2022-07-01
Accepted
2022-07-01 17:20:56
Documents
9
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 PREM14A a2022preliminaryproxystate.htm PREM14A 3208961
2 EX-FILING FEES exhibit107-preliminaryprox.htm EX-FILING FEES 15877
3 annexb1aa.jpg GRAPHIC 16478
4 annexb2aa.jpg GRAPHIC 36589
5 biohavenlogoa.jpg GRAPHIC 45274
6 innisfree_awxlogoxrxrgba.jpg GRAPHIC 94963
7 picture1a.jpg GRAPHIC 42626
8 proxycardimage1.jpg GRAPHIC 159089
9 proxycardimage2.jpg GRAPHIC 116761
  Complete submission text file 0001628280-22-018405.txt   3923799
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-38080 | Film No.: 221062410
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences